You just read:

Merck KGaA, Darmstadt, Germany, Presents Phase II Data on the Safety and Efficacy of Atacicept at the 2016 ACR/ARHP Annual Meeting

News provided by

Merck KGaA, Darmstadt, Germany

02 Nov, 2016, 08:00 ET